Escitalopram Supplier-Buyer Network — Trade Flow Analysis

Name: Escitalopram Supplier-Buyer Trade Network Dataset — 231+ Indian Exporters, 16+ Importers, 95+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Escitalopram supplier network, Escitalopram buyers, pharmaceutical export India, Escitalopram trade data

TransData Nexus

Escitalopram

India Pharmaceutical Trade Intelligence

$196.7M231 Suppliers95 CountriesHS 30049099

ExportsIndia → MOROCCO40.9%India → UNITED STATES23.6%

ImportsCANADA → India$5.3M UNITED STATES → India$18.4K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

Who Supplies Escitalopram? Top Manufacturers & Buyers 2026 — MEDISPRAY LABORATORIES PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1MEDISPRAY LABORATORIES PRIVATE LIMITED

MEDISPRAY LABORATORIES PRIVATE LIMITED is the first-largest Escitalopram exporter from India, with a market share of 39.3% and a total export value of $77.3M across 77 shipments. Their average shipment value of $1.0M is above the market average of $36.1K, suggesting premium or bulk contract pricing.

MEDISPRAY LABORATORIES PRIVATE LIMITED serves 3 named buyers in our database. CIPLA MAROC is the dominant customer, accounting for 99.5% of this supplier's tracked business. Top customers include:

• CIPLA MAROC — $77.0M across 77 shipments (99.5% of this supplier's total exports)

• CIPLA MAROC ANGLE RU — $214.9K across 0 shipments (0.3% of this supplier's total exports)

• CIPLA MAROC — $135.2K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: MEDISPRAY LABORATORIES PRIVATE LIMITED's per-shipment value of $1.0M is 2686% above the market average of $36.1K, consistent with large-order contracts or value-added formulations.

2TORRENT PHARMACEUTICALS LTD

TORRENT PHARMACEUTICALS LTD is the second-largest Escitalopram exporter from India, with a market share of 5.8% and a total export value of $11.5M across 242 shipments. Their average shipment value of $47.4K is above the market average of $36.1K, suggesting premium or bulk contract pricing.

TORRENT PHARMACEUTICALS LTD serves 5 named buyers in our database. TORRENT PHARMA INC is the dominant customer, accounting for 72.3% of this supplier's tracked business. Top customers include:

• TORRENT PHARMA INC — $8.3M across 175 shipments (72.3% of this supplier's total exports)

• TORRENT PHARMA INC IMPORTER EIN 36-4547412 — $1.4M across 30 shipments (12.4% of this supplier's total exports)

• HEUMANN PHARMA GMBH — $806.5K across 17 shipments (7.0% of this supplier's total exports)

• DKSH MALAYSIA SDN BH — $526.1K across 11 shipments (4.6% of this supplier's total exports)

• HEUMANN PHARMA GMBH — $422.6K across 9 shipments (3.7% of this supplier's total exports)

Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $47.4K is 32% above the market average of $36.1K, consistent with large-order contracts or value-added formulations.

3AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the third-largest Escitalopram exporter from India, with a market share of 4.8% and a total export value of $9.5M across 605 shipments. Their average shipment value of $15.6K is below the market average of $36.1K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROLOGISTICS LLC AUROBINDO PHARM — $4.3M across 278 shipments (46.0% of this supplier's total exports)

• AUROLOGISTICS LLC AUROBINDO PHARM — $1.9M across 122 shipments (20.1% of this supplier's total exports)

• AUROLOGISTICS LLC — $1.1M across 71 shipments (11.7% of this supplier's total exports)

• AURO PHARMA INC, — $1.1M across 69 shipments (11.5% of this supplier's total exports)

• APL SWIFT SERVICES ( — $1.0M across 65 shipments (10.7% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (605 shipments) at a per-shipment value of $15.6K, indicating a broad distribution network with many smaller, regular orders.

4AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED is the fourth-largest Escitalopram exporter from India, with a market share of 3.7% and a total export value of $7.3M across 218 shipments. Their average shipment value of $33.5K is below the market average of $36.1K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROLOGISTICS LLC AUROBINDO PHARM — $3.5M across 104 shipments (47.6% of this supplier's total exports)

• AUROLOGISTICS LLC — $1.8M across 53 shipments (24.4% of this supplier's total exports)

• AUROLOGISTICS LLC AUROBINDO PHARM — $717.3K across 21 shipments (9.8% of this supplier's total exports)

• AUROLOGISTICS LLC AUROBINDO PHARM — $669.1K across 20 shipments (9.2% of this supplier's total exports)

• AUROLOGISTICS LLC AUROBINDO PHARM — $653.1K across 20 shipments (8.9% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LIMITED operates with high shipment frequency (218 shipments) at a per-shipment value of $33.5K, indicating a broad distribution network with many smaller, regular orders.

5SANDOZ PRIVATE LIMITED

SANDOZ PRIVATE LIMITED is the fifth-largest Escitalopram exporter from India, with a market share of 3.4% and a total export value of $6.7M across 281 shipments. Their average shipment value of $23.8K is below the market average of $36.1K, reflecting a high-volume, competitive pricing strategy.

SANDOZ PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• LEK S.A. — $2.8M across 117 shipments (41.5% of this supplier's total exports)

• LEK S.A. — $2.1M across 87 shipments (30.9% of this supplier's total exports)

• SANDOZ DO BRASIL IND FARMACEUTICA — $904.8K across 38 shipments (13.5% of this supplier's total exports)

• SAMIL PHARMACEUTICAL — $579.1K across 24 shipments (8.7% of this supplier's total exports)

• SANDOZ DO BRASIL IND FARMACEUTICA — $361.6K across 15 shipments (5.4% of this supplier's total exports)

Key Insight: SANDOZ PRIVATE LIMITED operates with high shipment frequency (281 shipments) at a per-shipment value of $23.8K, indicating a broad distribution network with many smaller, regular orders.

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Escitalopram exporter from India, with a market share of 2.0% and a total export value of $3.9M across 293 shipments. Their average shipment value of $13.3K is below the market average of $36.1K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM — $1.4M across 106 shipments (36.0% of this supplier's total exports)

• RANBAXY (THAILAND) C — $855.6K across 64 shipments (22.0% of this supplier's total exports)

• M S SUN PHARMACEUTIC — $770.0K across 58 shipments (19.8% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $518.7K across 39 shipments (13.3% of this supplier's total exports)

• M S SUN PHARMACEUTIC — $349.3K across 26 shipments (9.0% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (293 shipments) at a per-shipment value of $13.3K, indicating a broad distribution network with many smaller, regular orders.

1Morocco

Morocco ranks as the first-largest destination for Escitalopram imports from India, with a total trade value of $80.4M across 71 shipments — representing a 40.9% share of all Escitalopram exports. The average shipment value of $1.1M is above the global average of $36.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Escitalopram importers in Morocco: CIPLA MAROC is the largest buyer, accounting for 96.0% ($77.2M) of this market's total imports.

• CIPLA MAROC — $77.2M (96.0% of Morocco's total)

Key Insight: Morocco's per-shipment average of $1.1M (3041% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Morocco is a key market for Escitalopram imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Escitalopram imports from India, with a total trade value of $46.5M across 514 shipments — representing a 23.6% share of all Escitalopram exports. The average shipment value of $90.4K is above the global average of $36.1K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.

Named Escitalopram importers in United States: TORRENT PHARMA INC is the largest buyer, accounting for 23.0% ($10.7M) of this market's total imports.

• TORRENT PHARMA INC — $10.7M (23.0% of United States's total)

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $4.8M (10.4% of United States's total)

• AUROLOGISTICS LLC AUROBINDO PHARM — $3.5M (7.5% of United States's total)

Key Insight: United States's per-shipment average of $90.4K (151% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Escitalopram imports from India.

Primary Market

Secondary Market

3Australia

Australia ranks as the third-largest destination for Escitalopram imports from India, with a total trade value of $8.3M across 27 shipments — representing a 4.2% share of all Escitalopram exports. The average shipment value of $307.6K is above the global average of $36.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Escitalopram importers in Australia: SANDOZ PTY LTD, is the largest buyer, accounting for 20.8% ($1.7M) of this market's total imports.

• SANDOZ PTY LTD, — $1.7M (20.8% of Australia's total)

Key Insight: Australia's per-shipment average of $307.6K (753% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Escitalopram imports from India.

Primary Market

Secondary Market

4Canada

Canada ranks as the fourth-largest destination for Escitalopram imports from India, with a total trade value of $7.7M across 61 shipments — representing a 3.9% share of all Escitalopram exports. The average shipment value of $126.9K is above the global average of $36.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Escitalopram importers in Canada: AURO PHARMA INC, is the largest buyer, accounting for 19.4% ($1.5M) of this market's total imports.

• AURO PHARMA INC, — $1.5M (19.4% of Canada's total)

• APOTEX INC, — $1.3M (17.4% of Canada's total)

Key Insight: Canada's per-shipment average of $126.9K (252% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Escitalopram imports from India.

Primary Market

Secondary Market

5Poland

Poland ranks as the fifth-largest destination for Escitalopram imports from India, with a total trade value of $6.9M across 143 shipments — representing a 3.5% share of all Escitalopram exports. The average shipment value of $48.4K is above the global average of $36.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Escitalopram importers in Poland: LEK S.A. is the largest buyer, accounting for 59.2% ($4.1M) of this market's total imports.

• LEK S.A. — $4.1M (59.2% of Poland's total)

• LEK S A — $2.1M (29.9% of Poland's total)

Key Insight: Poland's per-shipment average of $48.4K (34% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Poland is a key market for Escitalopram imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Escitalopram.
2.Flow Mapping: 231 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 5,457 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 95 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

5,457 Verified Shipments

231 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Escitalopram

Escitalopram

Who Supplies Escitalopram? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Escitalopram? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Escitalopram Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MEDISPRAY LABORATORIES PRIVATE LIMITED

2TORRENT PHARMACEUTICALS LTD

3AUROBINDO PHARMA LTD

4AUROBINDO PHARMA LIMITED

5SANDOZ PRIVATE LIMITED

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

From Indian Factories to Global Pharmacies — How Escitalopram Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Escitalopram Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Morocco

2United States

3Australia

4Canada

5Poland

People Also Ask — Escitalopram Supplier & Trade Network

Escitalopram Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology